A A A
-->

Klinische Studien

Chordome / Chondrosarkome:

SB CHORDOM
SB CHONDROSARCOM
OSCAR (H1 + C12 boost; inoperable osteosarkoma)
ISAC (C12/H1 for sacral chordoma)

Glioblastome:

CLEOPATRA (H1 vs. C12 boost RT; prim. glioblastoma) 
CINDERELLA (C12 recurrent gliobastoma) 

Meningeome:

MARCIE (C12 boost RT, meningeomas grade 2)

Speicheldrüsenkarzinome:

COSMIC (C12 boost RT; salivary glands)              
ACCEPT (C12 boost RT + Erbitux for ACC)

HNO-Tumore:

TPF-C HIT (C12 boost RT; head&neck)                                                                
IMRT HIT-SNT (C12 boost RT; sinu-nasal cancer)                                            
ACCEPT (C12 boost RT + Erbitux for ACC)

Hepatozellulläres Karzinom HCC:

PROMETHEUS (C12 for HCC)

Rektumkarzinomrezidiv:

PANDORA (C12 for recurrent rectal carcinoma)

Prostatakarzinom:

IPI (C12/H1 for prostate cancer)                                                                                           
PROLOG (hypofract. H1 for prostate cancer recurrence)           
KOLOG (hypofract. C12 for Prostate cancer recurrence)

Lungentumoren (NSCLC/Pancoast):

INKA (neoadj. C12 for inop. sulcus superior tumors)
 

Weiterführende Informationen, zu welchen Tumorerkrankungen Studien im MIT durchgeführt werden können, finden Sie auf unserer gemeinsamen Internetseite: http://mit-marburg.de/forschung/klinische-studien/